Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic evaluation studies in nuclear medicine: the need for standardization.

M Dietlein1, W H Knapp, K W Lauterbach

  • 1Department of Nuclear Medicine, University of Cologne, Germany.

European Journal of Nuclear Medicine
|June 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib.

Lung cancer (Amsterdam, Netherlands)·2013
Same author

Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.

Nuklearmedizin. Nuclear medicine·2013
Same author

Diagnostic value and therapeutic impact of (18)F-FDG-PET/CT in differentiated thyroid cancer. Results of a German multicentre study.

Nuklearmedizin. Nuclear medicine·2012
Same author

Calcitonin screening in patients with thyroid nodules. Diagnostic value.

Nuklearmedizin. Nuclear medicine·2012
Same author

123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.

Nuklearmedizin. Nuclear medicine·2012
Same author

[Thyroid disorders].

Versicherungsmedizin·2012
Same journal

[Not Available].

European journal of nuclear medicine·2016
Same journal

A Window on Latin America.

European journal of nuclear medicine·2016
Same journal

Erratum: Eur J Nucl Med (1999) 26: 686-692.

European journal of nuclear medicine·2016
Same journal

Nuclear medicine in the next decade.

European journal of nuclear medicine·2014
Same journal

Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis.

European journal of nuclear medicine·2014
Same journal

(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.

European journal of nuclear medicine·2014
See all related articles

Economic evaluations in nuclear medicine guide healthcare decisions by assessing cost-effectiveness. Key elements include specifying interventions, outcomes, and uncertainties for reliable analysis.

Area of Science:

  • Health Economics
  • Nuclear Medicine
  • Decision Analysis

Background:

  • Economic evaluations are crucial for publishing healthcare analyses, requiring clear statements on economic importance and viewpoint.
  • Key components include defining alternative interventions, evaluation methods, outcome measures, costing, time horizon, and uncertainty analysis.

Purpose of the Study:

  • To outline the essential components for conducting and publishing economic evaluations in healthcare.
  • To highlight the significance of outcome measures and provide examples of economic evaluations in nuclear medicine.

Main Methods:

  • Decision analysis based on clinical trial data, databases, or modeling.
  • Cost-effectiveness analysis, often using natural units for benefits, is prevalent in nuclear medicine.

Related Experiment Videos

  • Utilizing various endpoints like procedures avoided, survival probability, quality of life, and surrogate markers.

    • Main Results:

    • Nuclear medicine commonly employs cost-effectiveness analysis with natural units.
    • Examples demonstrate the application of economic evaluations for FDG-PET, scintigraphy, and radioiodine therapy.
    • Surrogate endpoints limit comparability; quality-adjusted life years (QALYs) are less frequently used.

    Conclusions:

    • Standardized reporting of economic evaluations ensures clarity and comparability.
    • Nuclear medicine studies benefit from robust economic evaluations to inform clinical practice and guidelines.
    • Multidisciplinary collaboration is essential for integrating nuclear medicine procedures into management guidelines.